In the BioHarmony Drug Report Database
Phenytoin
Dilantin (phenytoin) is a small molecule pharmaceutical. Phenytoin was first approved as Dilantin on 1982-01-01. It is used to treat epilepsy, status epilepticus, temporal lobe epilepsy, and tonic-clonic epilepsy in the USA. The pharmaceutical is active against sodium channel protein type 2 subunit alpha.
Trade Name
|
Dilantin |
|---|---|
Common Name
|
phenytoin |
ChEMBL ID
|
CHEMBL16 |
Indication
|
epilepsy, status epilepticus, temporal lobe epilepsy, tonic-clonic epilepsy |
Drug Class
|
Antiepileptics (hydantoin derivatives) |
Image (chem structure or protein)